Tyler S Bartholomew1, Hansel E Tookes2, Corinne Bullock3, Jason Onugha3, David W Forrest4, Daniel J Feaster3. 1. Department of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA. Electronic address: tsb61@miami.edu. 2. Division of Infectious Diseases, Miller School of Medicine, University of Miami, Miami, FL, USA. 3. Department of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA. 4. Department of Anthropology, College of Arts and Sciences, University of Miami, Miami, FL, USA.
Abstract
INTRODUCTION: Injection drug use (IDU) remains a significant public health problem. IDU has been associated closely with the opioid crisis; driving overdose, HIV, and Hepatitis C (HCV) infection nationwide. Syringe services programs (SSPs) remain pivotal evidence-based interventions to reduce harm and engage subgroups of people who inject drugs (PWID). This study aims to provide policy considerations from the IDEA SSP, the first legal SSP in the state of Florida. METHODS: We performed a latent class analysis on patterns of substance use among participants (N = 982) newly enrolled in a syringe services program (SSP). Associations between classes of substance use and sociodemographic variables, risky injection and sex behaviors, HIV/HCV status and syringe coverage were analyzed using the R3STEP and BCH 3-step procedures in latent class regression. RESULTS: We found a three-class solution: Heroin-Dominant class (73.9%), Methamphetamine-Dominant class (9.5%) and Heroin/Cocaine class (16.6%). Compared to Heroin-Dominant class, the Heroin/Cocaine class were more likely to report homelessness, sharing works, unprotected sex, public injection, and to be HCV positive. Compared to both Heroin-Dominant and Heroin/Cocaine classes, the Methamphetamine-Dominant class were more likely to be male, Hispanic, gay or bisexual orientation, HIV positive, to report unprotected sex and sex with PWID. In addition, the lowest and highest syringe coverage were among those in the Heroin/Cocaine and Methamphetamine-Dominant classes, respectively. CONCLUSION: Existing interventions among this population to mitigate infectious disease risk, such as SSPs, can be a used to engage differing PWID populations. However, multi-component, targeted preventive interventions and need-based syringe distribution policies are required to further reduce HIV and HCV risk among various PWID populations.
INTRODUCTION: Injection drug use (IDU) remains a significant public health problem. IDU has been associated closely with the opioid crisis; driving overdose, HIV, and Hepatitis C (HCV) infection nationwide. Syringe services programs (SSPs) remain pivotal evidence-based interventions to reduce harm and engage subgroups of people who inject drugs (PWID). This study aims to provide policy considerations from the IDEA SSP, the first legal SSP in the state of Florida. METHODS: We performed a latent class analysis on patterns of substance use among participants (N = 982) newly enrolled in a syringe services program (SSP). Associations between classes of substance use and sociodemographic variables, risky injection and sex behaviors, HIV/HCV status and syringe coverage were analyzed using the R3STEP and BCH 3-step procedures in latent class regression. RESULTS: We found a three-class solution: Heroin-Dominant class (73.9%), Methamphetamine-Dominant class (9.5%) and Heroin/Cocaine class (16.6%). Compared to Heroin-Dominant class, the Heroin/Cocaine class were more likely to report homelessness, sharing works, unprotected sex, public injection, and to be HCV positive. Compared to both Heroin-Dominant and Heroin/Cocaine classes, the Methamphetamine-Dominant class were more likely to be male, Hispanic, gay or bisexual orientation, HIV positive, to report unprotected sex and sex with PWID. In addition, the lowest and highest syringe coverage were among those in the Heroin/Cocaine and Methamphetamine-Dominant classes, respectively. CONCLUSION: Existing interventions among this population to mitigate infectious disease risk, such as SSPs, can be a used to engage differing PWID populations. However, multi-component, targeted preventive interventions and need-based syringe distribution policies are required to further reduce HIV and HCV risk among various PWID populations.
Authors: Kyle Hunter; Ju Nyeong Park; Sean T Allen; Patrick Chaulk; Taeko Frost; Brian W Weir; Susan G Sherman Journal: Int J Drug Policy Date: 2018-04-13
Authors: Rebecca C Trenz; Michael Scherer; Alexandra Duncan; Paul T Harrell; Anne Gloria Moleko; William W Latimer Journal: Drug Alcohol Depend Date: 2013-04-03 Impact factor: 4.492
Authors: Meredith C Meacham; Abby E Rudolph; Steffanie A Strathdee; Melanie L Rusch; Kimberly C Brouwer; Thomas L Patterson; Alicia Vera; Gudelia Rangel; Scott C Roesch Journal: Subst Use Misuse Date: 2015-10-07 Impact factor: 2.164
Authors: David W Forrest; Lisa R Metsch; Marlene LaLota; Gabriel Cardenas; Dano W Beck; Yves Jeanty Journal: J Urban Health Date: 2010-01-26 Impact factor: 3.671
Authors: Rachel E Gicquelais; Becky L Genberg; Jacquie Astemborski; David D Celentano; Gregory D Kirk; Shruti H Mehta Journal: AIDS Educ Prev Date: 2019-08
Authors: Kirsten M A Trayner; Andrew McAuley; Norah E Palmateer; David J Goldberg; Samantha J Shepherd; Rory N Gunson; Emily J Tweed; Saket Priyadarshi; Catriona Milosevic; Sharon J Hutchinson Journal: Int J Drug Policy Date: 2020-01-22
Authors: Teresa A Chueng; Hansel E Tookes; Megan McLaughlin; Angela M Arcaro-Vinas; David P Serota; Tyler S Bartholomew Journal: Subst Use Misuse Date: 2022-06-10 Impact factor: 2.362
Authors: Sean T Allen; Rebecca Hamilton White; Allison O'Rourke; Kristin E Schneider; Brian W Weir; Gregory M Lucas; Michael E Kilkenny; Susan G Sherman Journal: AIDS Behav Date: 2021-04-22
Authors: Tyler S Bartholomew; Jason Onugha; Corinne Bullock; Carolina Scaramutti; Hardik Patel; David W Forrest; Daniel J Feaster; Hansel E Tookes Journal: Harm Reduct J Date: 2020-06-10
Authors: Cecile M Denis; Tiffany Dominique; Peter Smith; Danielle Fiore; Yi-Chien Ku; Angus Culhane; Debora Dunbar; Dana Brown; Menvekeh Daramay; Chelsea Voytek; Knashawn H Morales; Michael B Blank; Paul F Crits-Christoph; Steven D Douglas; Serguei Spitsin; Ian Frank; Krystal Colon-Rivera; Luis J Montaner; David S Metzger; Dwight L Evans Journal: AIDS Behav Date: 2021-01-15
Authors: Jennifer R Havens; Hannah K Knudsen; Justin C Strickland; April M Young; Shanna Babalonis; Michelle R Lofwall; Sharon L Walsh Journal: Front Psychiatry Date: 2022-01-07 Impact factor: 4.157